Abstract: High consumption of fructose-sweetened beverages has been linked to a high prevalence of chronic metabolic diseases. We have previously shown that a short course of fructose supplementation as a liquid solution induces glucose intolerance in female rats. In the present work, we characterized the fructose-driven changes in the liver and the molecular pathways involved. To this end, female rats were supplemented or not with liquid fructose (10% w/v) for 7 or 14 days. Glucose and pyruvate tolerance tests were performed, and the expression of genes related to insulin signaling, gluconeogenesis and nutrient sensing pathways was evaluated. Fructose-supplemented rats showed increased plasma glucose excursions in glucose and pyruvate tolerance tests and reduced hepatic expression of several genes related to insulin signaling, including insulin receptor substrate-2 (IRS-2). However, the expression of key gluconeogenic enzymes, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase, was reduced. These effects were caused by an inactivation of hepatic forkhead box O1 (FoxO1) due to an increase in its acetylation state driven by a reduced expression and activity of sirtuin 1 (SIRT1). Further contributing to FoxO1 inactivation, fructose consumption elevated liver expression of the spliced form of X-box-binding-protein-1, as a consequence of an increase in the activity of the mammalian target of rapamycin 1 and protein 38-mitogen activated protein kinase (p38-MAPK). Liquid fructose affects both insulin signaling (IRS-2 and FoxO1) and nutrient sensing pathways (p38-MAPK, mTOR and SIRT1) thus disrupting hepatic insulin signaling without increasing the expression of key gluconeogenic enzymes. High consumption of fructose-sweetened beverages has been linked to a high prevalence of chronic metabolic diseases. We have previously shown that a short course of fructose supplementation as a liquid solution induces glucose intolerance in female rats. In the present work, we characterized the fructose-driven changes in the liver and the molecular pathways involved. To this end, female rats were supplemented or not with liquid fructose (10% w/v) for 7 or 14 days. Glucose and pyruvate tolerance tests were performed, and the expression of genes related to insulin signaling, gluconeogenesis and nutrient sensing pathways was evaluated.
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Abstract:
High consumption of fructose-sweetened beverages has been linked to a high prevalence of chronic metabolic diseases. We have previously shown that a short course of fructose supplementation as a liquid solution induces glucose intolerance in female rats. In the present work, we characterized the fructose-driven changes in the liver and the molecular pathways involved. To this end, female rats were supplemented or not with liquid fructose (10% w/v) for 7 or 14 days. Glucose and pyruvate tolerance tests were performed, and the expression of genes related to insulin signaling, gluconeogenesis and nutrient sensing pathways was evaluated.
Fructose-supplemented rats showed increased plasma glucose excursions in glucose and pyruvate tolerance tests and reduced hepatic expression of several genes related to insulin signaling, including insulin receptor substrate-2 (IRS-2).
However, the expression of key gluconeogenic enzymes, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase, was reduced. These effects were caused by an inactivation of hepatic forkhead box O1 (FoxO1) due to an increase in its acetylation state driven by a reduced expression and activity of sirtuin 1 (SIRT1).
Further contributing to FoxO1 inactivation, fructose consumption elevated liver expression of the spliced form of X-box-binding-protein-1, as a consequence of an increase in the activity of the mammalian target of rapamycin 1 and protein 38-mitogen activated protein kinase (p38-MAPK). Liquid fructose affects both insulin signaling (IRS-2 and FoxO1) and nutrient sensing pathways (p38-MAPK, mTOR and SIRT1) thus disrupting hepatic insulin signaling without increasing the expression of key gluconeogenic enzymes.
Introduction
During the last decade, there has been an increasing number of published epidemiological and interventional studies on human populations linking the high consumption of sugar-sweetened beverages, enriched in simple sugars such as fructose and glucose, to the high prevalence of chronic metabolic and related cardiovascular diseases [1] [2] [3] [4] . These diseases include dyslipidemia [5, 6] , gout [7] , hypertension [8, 9] , obesity [10, 11] , insulin resistance [12] and type 2 diabetes mellitus [10, [13] [14] [15] . High energy intake, lack of adequate energy compensation through a proportional decrease in the amount of energy ingested as solid foods, and the special metabolism of fructose, have been reported to contribute to this possible causal association [2, 3] .
Among the experimental animal models used, fructose-fed rats can reproduce metabolic alterations induced by fructose consumption in humans. Rats, like humans, cannot transform ingested fructose into glucose [16] . Moreover, in both rats and humans, continuous fructose ingestion induces the expression of fructokinase, an enzyme that drives fructose into liver metabolic pathways [17] [18] [19] . The changes associated with the human metabolic syndrome can be reproduced in rats by providing them fructose as a 10% w/v solution [20] [21] [22] . This mimics the level of dietary consumption of sweetened beverages (as a percentage of the daily caloric intake about 30%) that leads to clear metabolic disturbances in humans [23, 24] .
Using this model, we recently discovered a gender difference in the response to fructose-consumption, with clear signs of glucose intolerance after a short 14-day course of fructose supplementation in female, but not male, rats [17] . We also found 5 that fructose-fed female rats displayed a significantly reduced expression of liver insulin-related substrate-2 (IRS-2) [17] , one of the key insulin-signaling proteins in the liver [25] .
We therefore pursued the search for the molecular mechanism underlying the glucose intolerance observed after fructose supplementation in female rats. In the present work, we show that fructose induces a set of complex molecular alterations in the liver expression of nutrient sensing factors which reduces the expression of both liver IRS-2 and gluconeogenic enzymes in fructose-supplemented female rats.
Methods

Animals and experimental design
Female Sprague-Dawley rats purchased from Charles River (Barcelona, Spain) were maintained with water and food ad libitum at constant humidity and temperature with a light/dark cycle of 12 hours. The animals were randomly separated into a control and a fructose-supplemented group (8 and 12 rats per group, respectively). Fructose was supplied as a 10 % (weight/volume) solution in drinking water for 7 and 14 days. Control animals received no supplementary sugar.
At the end of this period, animals were killed by decapitation under isoflurane anesthesia at 10 a.m. Food and fructose solution were removed at 8 a.m. To reduce the variability in plasma estrogen concentrations, female rats were killed during the diestrus period.
Subgroups of female rats were randomly separated into control and fructosesupplemented groups, as described above, for glucose and pyruvate tolerance tests. 
RNA preparation and analysis
Total RNA was isolated using the TrizolR reagent (Invitrogen, Life Technologies, Madrid, Spain). The levels of specific mRNAs were assessed by realtime reverse transcription-polymerase chain reaction (RT-PCR) using Sybergreen PCR Master Mix, specific primers and the Applied Biosystems One-
Step Plus sequence detection system (Applied Biosystems, Foster City,CA). For G6Pc, PEPCK and XBP-1, we used conventional RT-PCR as described previously [34] . Adenosyl phosphoribosyl transferase (APRT) or 18S was used as an internal control. The primer sequences, resulting PCR products and number of cycles are listed in Supporting Table 1 .
Western-blot analysis
Ten to thirty micrograms of different protein fractions from the rat livers were subjected to SDS-polyacrylamide gel electrophoresis. Proteins were then transferred to Immobilon polyvinylidene difluoride transfer membranes (Millipore, Billerica, MA), blocked for 1 h at room temperature with 5% non-fat milk solution in 0.1% Tween-20-Tris-buffered saline (TBS), and incubated as described previously [21] . Detection was performed with the ECL chemiluminescence kit for HRP (Amersham GE Healthcare Europe GmbH, Barcelona, Spain). To confirm the uniformity of protein loading, the blots were incubated with the -actin or -tubulin antibody (SigmaAldrich, St. Louis, MO) as a control. The size of the detected proteins was estimated using protein molecular-mass standards (Invitrogen, Life Technologies, Madrid, Spain). Antibodies were obtained from Santa Cruz Technologies (Santa Cruz, CA), except those for phospho-and total protein kinase B or Akt, phospho-and total p38-MAPK and PP2Ac, which were obtained from Cell Signaling (Danvers, MA), and phospho-and total mTOR, purchased from Millipore (Billerica, MA).
Co-immunoprecipitation
Two hundreds micrograms of protein extracts were precleared in preclearing matrix F (Santa Cruz Biotechnology, Santa Cruz, CA) for 2 h at 4 ºC, and the resulting supernatant was immunoprecipitated for 4 h at 4 °C with 4 μg of anti-acetyllysine (Cell Signalling, Denvers, MA) in a final volume of 0.5 mL made up with buffer containing 10 mM phosphate-buffered saline (PBS) and 2% bovine serum albumin (BSA). Immunocomplexes were captured by incubating the samples with protein Aagarose suspension (Santa Cruz Biotechnology, Santa Cruz, CA) overnight at 4 °C on a rocker platform. Agarose beads were collected by centrifugation and washed three times with PBS-containing protease inhibitors. After microcentrifugation, the pellet was re-suspended with 60 μL of SDS-PAGE sample buffer and boiled for 5 min at 100 °C. The supernatant was subjected to electrophoresis on 10% SDS-PAGE and immunoblotted with an antibody against FoxO1 (Santa Cruz Biotechnology, Santa Cruz, CA).
PCR-arrays
Total RNA was isolated from control and fructose-fed rats as described above, and then purified using RNeasy kit columns (Qiagen Iberia, Madrid, Spain). Single stranded cDNA and PCR arrays were performed using the Rat Insulin Signaling Pathway RT 2 Profiler PCR Array (PARN-030E) from SABiosciences (Quiagen Iberia, Madrid, Spain), following the manufacturer's guidelines. Array data processing and analysis were performed using a Web portal from SABiosciences.
Statistics
The results are expressed as the mean of n values  standard deviation.
Plasma samples were assayed in duplicate. Significant differences were established by the unpaired t-test, one-way ANOVA test (with a posteriori analysis) for cellculture experiments, or the two-way ANOVA test (with a posteriori analysis) for plasma analytes, using the computer program GraphPad InStat (GraphPad Software V2.03). When the number of animals was too small or the variance was not homogeneous, a non-parametric Mann-Whitney test was performed for comparing two groups. * P < 0.05, ** P < 0.01; # P < 0.001 14-day control vs 7-day control, in Tables and Figures. Results A 14-day course of fructose ingestion in liquid form is sufficient to induce glucose intolerance in female Sprague-Dawley rats. Fructose administration as a 10 % weight/volume liquid solution to female Sprague-Dawley rats increased energy intake by 26% and 29% after 7-and 14 days of supplementation, respectively, compared to the amount of energy consumed by control animals, despite fructose-supplemented rats reducing the ingestion of their solid diet by 22%. In agreement with our previous results [17] , fructose consumption by female rats did not modify body weight, but increased plasma glucose and insulin concentrations only after the 14-day course of fructose-supplementation, thus significantly reducing the insulin sensitivity index (ISI) in these animals (Table 1) .
Furthermore, only the rats supplemented for 14 days displayed changes in their glucose tolerance test (GTT), with a significant 30% increase in the area under the curve (AUC) value for plasma glucose concentration (Table 1) . Again, confirming our previous results [17] , livers from 14-day fructose-supplemented rats showed a marked reduction in the expression of IRS-2 protein (Figure 1a) , the main transducer of insulin signaling in liver tissue [28] , and a significant increase (1.28-fold) Procedures) to liver samples obtained from female rats supplemented with fructose for 7-and 14-days. As shown in Table 2 , two clear patterns of changes in gene expression were detected: (1) an increase in the expression of genes related to lipid synthesis, such as acc (acetyl-CoA Carboxylase), fas (fatty acid synthase) and l-pk (liver-pyruvate kinase) at the two time-points studied; and (2) a decrease in the expression of genes related to insulin and insulin-growth factor signaling, such as irs-2, cap1 (adenylate cyclase associated protein 1), and dok1 and 3 (docking protein 1 and 3), confirming a deficit in the expression of key genes involved in insulin signal transduction. Surprisingly, the expression of two key gluconeogenic genes, g6pc
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(glucose-6-phosphatase) and pck (phosphoenolpyruvate carboxykinase or PEPCK), was hardly affected in the livers of 14-day fructose-supplemented rats. Theoretically, disrupted insulin-signalling should trigger an increase in liver gluconeogenesis, as
shown by the results obtained in the pyruvate-chalenge test (see Figure 1e and 1f) , mainly through the increased expression and activity of G6Pc and PEPCK [29] . In fact, when we reassessed the mRNA levels fof G6Pc and PEPCK using gene- Fructose significantly changes the activity and expression of key nutrient-sensing molecules in the liver. To decipher the complex changes induced by fructose in insulin signaling, we focused our attention on three key molecular transducers involved in nutrient sensing in liver cells: mTOR [33] , the stress kinase p-38 MAPK [34] , and SIRT1 [33] . As shown in Figure 5 , fructose enhanced the phosphorylated, active form of mTOR (Figure 5a ) (1.7-fold) and p-38 MAPK (Figure 5b ) (2.7-fold) only in the livers of 14-day fructose-supplemented rats.
On the contrary, SIRT1 protein levels were markedly reduced (Figure 6a ) (0.51-fold), again only in the livers of 14-day fructose-supplemented rats. To confirm that both SIRT1 expression and activity were decreased by fructose supplementation, we assessed the presence of one of its substrates, acetylated-FoxO1 [35] . Indeed, the amount of acetylated-FoxO1 was markedly increased in liver samples from 14-day fructose-supplemented rats (Figure 6b) , consistent with the decreased SIRT1 activity in these samples. When we assessed the effect of fructose on the expression of mTOR, p-38 MAPK and SIRT1 in FaO cells, only the phosphorylated, active form of p-38 MAPK was increased (1.23-fold, Supporting Figure 3b ).
Discussion
We previously demonstrated that a short course (14 days) of fructose supplementation as a liquid solution was sufficient to induce glucose intolerance only in female, but not male, rats [17] . In the present work, we detected a clear rise in the liver glucose output after a bolus administration of a direct gluconeogenic precursor, such a pyruvate, to 14-day fructose-supplemented rats. Higher than usual plasma concentrations of glucose in control animals were due to the fact that rats were fasted only two hours before sacrifice (see Animals and experimental design).
However, we were surprised to note a significant reduction in the expression of two key gluconeogenic enzymes, PEPCK and G6Pc, despite a clear impairment in insulin signaling in the livers of these rats. Thus, we searched for the molecular cues that could explain this situation. Our main findings indicate that through a complex chain of molecular changes affecting both insulin signalling (IRS-2 and FoxO1) and nutrient sensing pathways (p38-MAPK, mTOR and SIRT1), fructose metabolism in the liver disrupt insulin signalling without affecting, or even decreasing, the expression of key gluconeogenic enzymes. These results suggest that the path from fructose consumption to the production of insulin resistance is not as straightforward as previously thought. Moreover, these changes seem to be specifically related to fructose consumption, and not to general changes in the amount of solid food ingested or total energy intake. Although solid food consumption was reduced by 22% by fructose ingestion, the amount of macro-and micronutrients ingested daily by the fructose-supplemented animals was equally or above the estimated nutrient requirements for maintenance and growth of rats (see Supplemental Table 2 ).
Furthermore, we have shown previously that rats supplemented with a 10 % (weight/volume) liquid solution of glucose, despite ingesting the same amount of energy as rats supplemented with a 10% liquid solution of fructose, they did not show similar changes in main metabolic parameters, such as plasma and liver triglyceride, PPARα expression and β-oxidation activity [21] .
p38-MAPK is a stress-related kinase [34] whose activity can be increased by the metabolic burden imposed by fructose metabolism in hepatocytes through two mechanisms: increased activity of protein phosphatase 2A [36] and the presence of bacterial toxins in blood, as a result of fructose-mediated changes in the intestinal barrier permeability [37, 38] . Indeed, we could detect a clear increase in the phosphorylated, activated form of p38-MAPK only in the liver samples of 14-day fructose-supplemented rats, which coincided with an increased expression of the catalytic form of PP2A.
It has been described that increased p38-MAPK activity, by phosphorylating the tuberous sclerosis 2 gene product or tuberin, could release its inhibitory activity on mTORC1 (mammalian Target of Rapamicyn Complex 1) [39] . The mTOR signaling pathway transduces information from different signals, such as growth factors, amino acids, and energy overload in the cell [40] . In accordance with an increased energy load and p38-MAPK activity, liver samples from 14-day fructosesupplemented rats showed a clear increase in the phosphorylated, activated form of mTOR. As it has been shown that mTOR activation causes IRS-2 degradation [41] , the increase in mTOR activity could be the final factor resulting in the decreased liver expression of IRS-2 induced by fructose-consumption. Furthermore, since p38-MAPK can phosphorylate FoxO1 [42] , the increased p38-MAPK activity could explain the elevated amount of phosphorylated, inactive FoxO1 in the livers of 14-day supplemented rats, despite the lack of insulin-mediated Akt activation.
FoxO1 presented two other anomalies in the livers of 14-day supplemented rats, namely a reduction in its total cellular amount and a nuclear localization, despite being hyperphosphorylated. A recent report demonstrated that XBP-1, an endoplasmic reticulum stress transcription factor, plays an essential role in maintaining plasma glucose concentration and glucose tolerance [32] , interacting with FoxO1 and directing it toward proteasome degradation, as well as improving the control of plasma glucose concentrations even without enhancing insulin signalling.
Moreover, it has been described that mTORC1 activity increases the splicing of XBP-1 [43] , while p38-MAPK phosphorylates the splice-derived protein, facilitating its nuclear localization and activity [44] . Indeed, in accordance with the increased activity of mTOR and p38-MAPK, there was a marked increase in the spliced form of XBP-1 mRNA and nuclear protein in the livers of 14-day fructose-supplemented rats, thus giving a plausible explanation for the reduced amount of total FoxO1 protein in these samples.
FoxO1 activity can be regulated not only by phosphorylation, but also by acetylation. Liu et al. described that acetylated-FoxO1, although displaying reduced transcriptional activity, is retained mainly in the nucleus [45] . The NAD + -dependent deacetylase SIRT1 controls metabolic processes in response to low nutrient availability [46] , mediating the direct deacetylation of several transcription factors including FoxO1 [35] . Situations of energy overload, such as a high-fat diet, reduces SIRT1 expression and/or activity [47] . Consistently with the increased amount of energy consumed by fructose-supplemented rats, SIRT1 expression was significantly reduced in the livers of 14-day fructose-supplemented rats. As a consequence of the reduced deacetylation activity, the amount of acetylated-FoxO1 was increased in the same samples, thus explaining the increased nuclear localization of FoxO1 in the livers of fructose supplemented rats.
The combined increases in the liver activities of malate dehydrogenase and malic enzyme could explain the increased liver output of glucose in 14-day fructosesupplemented rats submitted to the pyruvate tolerance test, despite the reduced expression of both G6Pc and PEPCK. Nevertheless, this situation indicates that in these animals, the altered ISI is not due to an increased output of liver glucose. New experiments should be performed in order to ascertain the existence of a state of skeletal muscle insulin resistance in 14-day fructose-supplemented rats. Decreased muscular consumption of glucose could explain the observed increase in the AUC for the glucose tolerance test in 14-day fructose-supplemented rats.
Further studies using chronic fructose supplementation should be performed in order to ascertain whether this situation persists in time or evolves to a typical liver insulin resistance with increased gluconeogenesis. This is an important issue, given the epidemiological evidence relating consumption of fructose sweetened beverages over time and insulin resistance and type 2 diabetes mellitus in human populations. 
